Companion Society Meetings

Pulmonary Pathology Society

Current Issues in Pulmonary Pathology

Saturday, March 17, 2018, 7:00 - 10:00 PM

Session Credits:

3 CME

Moderators:

Soon Hee Jung, MD, Wonju Severance Christian Hospital, Wonju City, Republic of Korea
Donald Guinee, MD, Virginia Mason Medical Center, Seattle, WA

Course Description:

In this course, experts will provide updated information on major subjects in pulmonary pathology which currently impact the routine practice of surgical pathology and cytopathology and patient care. The material is presented by experts involved in the committees, organizations and/or studies which have developed or determined the revisions or advances in these topics. The topics to be covered include hypersensitivity pneumonitis, lung cancer screening, the new lung cancer biomarker testing guidelines and lung cancer staging. In addition, a pulmonologist and a pulmonary pathologist will lead the audience in an interactive multidisciplinary session in the step-by-step clinical/radiologic/histologic diagnosis of problem interstitial lung diseases.

Learning Objectives:

Upon completion of this educational activity, the learner will be able to:

  • Describe the various histopathologic manifestations of hypersensitivity pneumonitis and their differential diagnosis
  • Explain new recommendations in the fields of lung cancer screening, lung cancer biomarker testing and lung cancer staging
  • Diagnose interstitial lung diseases on the basis of combined pathologic, clinical and radiologic findings

 

7:00 PM Update on Hypersensitivity Pneumonitis
Andrew Churg, MD, University of British Columbia, Vancouver, BC, Canada
7:30 AM Lung Cancer Screening
Diana Ionescu, MD, British Columbia Cancer Agency, Vancouver, BC, Canada
8:00 PM The Revised CAP/IASLC/AMP Lung Cancer Biomarker Guidelines
Yasushi Yatabe, MD, PhD, Aichi Cancer Center, Nagoya, Japan
8:30 PM Updates in Lung Cancer Staging
Kirk Jones, MD, University of California, San Francisco, CA
9:00 PM Interactive Session on Interstitial Lung Diseases
Kirtee Raparia, Kaiser Permanante, Santa Clara, CA
Rishi Raj, MD, Stanford University, Palo Alto, CA

 

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and Pulmonary Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Return to 2018 Annual Meeting Companion Society Meetings Page

Meetings

view more